Creative Medical Technology

CELZNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$6.197 M

$0.94 -6.47%

Close of 22 Sept 2026

Revenue

$6.00K

#3630 by revenue

Earnings

-$6.00M

Loss-making

Shares outstanding

6,592,557

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#150Black TitanBTTC$7.75M
#151AIM ImmunoTechAIM$7.66M
#152Creative Medical TechnologyCELZ$6.20M
#153Liminatus PharmaLIMN$5.47M
#154PharmaCyte BiotechPMCB$4.92M

What if Creative Medical Technology were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,586,076

Per share 4,878,804× higher

Bitcoin $1.74T

$264,185.04

Per share 281,048× higher

Nvidia $5.52T

$836,665.75

Per share 890,070× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Creative Medical Technology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.